
Rifco 4gm/500mg Injection
Marketer
Aktimas Bio Pharmaceuticals Pvt Ltd
Salt Composition
Piperacillin (4gm) + Tazobactum (500mg)
Overview Rifco 4gm/500mg Injection
Cefixime and Sulbactam injection (4gm/500mg), marketed as Rifco, combats bacterial infections through a dual antibiotic action. This medication's administration is exclusively by a healthcare provider; self-injection is strictly prohibited. Dosage and frequency are tailored by your physician to your specific condition's severity. Always adhere to your doctor's prescribed regimen. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects warrant immediate medical attention. Prior to treatment, inform your doctor of any antibiotic allergies, liver or kidney impairments. Adjustments to dosage or alternative medications may be necessary. While generally safe during pregnancy and lactation under medical guidance, physician supervision is essential.
Uses of Rifco 4gm/500mg Injection
Infections caused by bacteria
Major Benefits of Rifco 4gm/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Rifco 4gm/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Rifco 4gm/500mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Rifco 4gm/500mg Injection works:
The injectable drug Rifco 4gm/500mg combines piperacillin, an antibiotic that disrupts bacterial cell wall synthesis, with tazobactam, a beta-lactamase inhibitor. This combination boosts piperacillin's effectiveness by overcoming bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between alcohol ingestion and Rifco 4gm/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Rifco 4gm/500mg is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no negative consequences for fetal development; however, data from human clinical trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Rifco, 4gm/500mg, poses no known breastfeeding risks. Research in humans indicates minimal drug transfer to breast milk, presenting no discernible harm to infants.
DrivingCONSULT YOUR DOCTOR
The impact of Rifco 4gm/500mg Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Rifco 4gm/500mg Injection to individuals with impaired renal function. Dosage modification of Rifco 4gm/500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Rifco 4gm/500mg Injection in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Rifco 4gm/500mg Injection :
Omit a Rifco 4gm/500mg Injection dose? Seek your physician's advice.
Facts to Know About Rifco 4gm/500mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Agents against infection |
